- Home
- BNR vs OM Comparison
BNR vs OM Comparison
Compare BNR & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNR | OM |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.7M | 63.9M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BNR | OM |
|---|---|---|
| Price | $18.50 | $3.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.33 |
| AVG Volume (30 Days) | 22.1K | ★ 189.8K |
| Earning Date | 03-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,476,000.00 |
| Revenue This Year | $111.65 | $9.16 |
| Revenue Next Year | N/A | $11.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $2.18 | $3.00 |
| 52 Week High | $41.72 | $21.98 |
Technical Indicators
Market Signals| Indicator | BNR | OM |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 47.28 |
| Support Level | $15.52 | $3.08 |
| Resistance Level | $24.23 | $3.69 |
| Average True Range (ATR) | 1.71 | 0.24 |
| MACD | 0.20 | 0.07 |
| Stochastic Oscillator | 45.63 | 65.55 |
Price Performance
Historical ComparisonAbout BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.